Cost of hemophilia A in Turkey: an economic disease burden analysis
Tarih
2021Yazar
Antmen, Bulent
Ar, Muhlis Cem
BALKAN, CAN
Kavakli, Kaan
Malhan, Simten
Oksuz, Ergun
Üst veri
Tüm öğe kaydını gösterÖzet
Objective: Hemophilia A is the second most common bleeding disorder causing patients to have lifelong follow-up and treatment. Despite being a rare disease, hemophilia A has a high economic burden on individuals and the public. The purpose of this study was to estimate the total disease cost of hemophilia A in Turkey.
Koleksiyonlar
- Makale [92796]